Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-03-30

FDA Approved: DEFERASIROX — Original Application (Ascend Laboratories, LLC)

View source ↗

Summary

FDA approves Deferasirox as an original ANDA submission by Ascend Laboratories, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Deferasirox (Deferasirox)

Snippet

ORIG AP for DEFERASIROX (DEFERASIROX)